Evidence map›Paper›PMID 23749144›Full record

ArticleNature neuroscience2013

TNFα reverse signaling promotes sympathetic axon growth and target innervation.

Lilian Kisiswa, Catarina Osório, Clara Erice, Thomas Vizard, Sean Wyatt, Alun M Davies

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Stellate Ganglia and Cardiac Sympathetic Overactivation in Heart Failure.International journal of molecular sciences · 2022
    Review
  4. RANKL biology.Bone · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. How CD40L reverse signaling regulates axon and dendrite growth.Cellular and molecular life sciences : CMLS · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. TNF-Mediated Homeostatic Synaptic Plasticity: FromFrontiers in cellular neuroscience · 2020
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lilian KisiswaDivision of Molecular Biosciences, School of Biosciences, Cardiff University, Cardiff, UK.
Catarina Osório
Clara Erice
Thomas Vizard
Sean Wyatt
Alun M Davies
Cardiff University · GBJohn Radcliffe Hospital · GB

Funding

Wellcome Trust 085984
6 · The paper itself

Abstract

Reverse signaling via members of the tumor necrosis factor (TNF) superfamily controls multiple aspects of immune function. Here we document TNFα reverse signaling in the nervous system to our knowledge for the first time and show that it has a crucial role in establishing sympathetic innervation. During postnatal development, sympathetic axons express TNFα as they grow and branch in their target tissues, which in turn express TNF receptor 1 (TNFR1). In culture, soluble forms of TNFR1 act directly on postnatal sympathetic axons to promote growth and branching by a mechanism that depends on membrane-integrated TNFα and on downstream activation of ERK. Sympathetic innervation density is substantially lower in several tissues in postnatal and adult mice lacking either TNFα or TNFR1. These findings reveal that target-derived TNFR1 acts as a reverse-signaling ligand for membrane-integrated TNFα to promote growth and branching of sympathetic axons.

Indexed as

ADAM17 ProteinADAM ProteinsAnimalsAnimals, NewbornAxonsCalciumCells, CulturedChelating AgentsDose-Response Relationship, DrugEgtazic AcidEmbryo, MammalianGene Expression Regulation, DevelopmentalMiceMice, TransgenicNerve FibersNerve Growth Factor1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acidADAM17 ProteinADAM ProteinsCalciumChelating AgentsEgtazic AcidNerve Growth FactorReceptors, Tumor Necrosis Factor, Type IRNA, MessengerTnfrsf1a protein, mouseTumor Necrosis Factor-alphaTyrosine 3-Monooxygenase

Identifiers

PMID23749144
PMCPMC3785146
OpenAlexW2040506298

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.